LPTX News and Press, Leap Therapeutics Inc. From 11/15/21

Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Nov. 15, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and ...

Leap Therapeutics (NASDAQ:LPTX): Q3 GAAP EPS of -$0.92. Cash, cash equivalents and marketable debt securities totaling $78M Press Release For further details see: Leap Therapeutics reports Q3 results

Leap Therapeutics Reports Third Quarter 2021 Financial Results PR Newswire CAMBRIDGE, Mass. , Nov. 12, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics...

Looking to catch lightning in a bottle? Penny stocks can be your hot ticket. But in today’s article, we’re not talking about safety first, we’re talking about high-risk, volatile trading. One of the most frequently discussed topics this year is short squeeze stocks. ...

LPTX has shown that it can surge on positive data. The trial from which this data came will be completed by year-end. I expect another small spike around that time. For further details see: Leap Therapeutics: Another Leap Coming Up

Leap Therapeutics is an early stage oncology company with a single active asset. Their single asset focuses on a pathway that is dysregulated in multiple cancers. Early data is a mixed bag, with potential efficacy seen in gastric cancer. Investing in Leap Therapeutics can be c...

The biotech industry continues to play a crucial role in developing solutions to treat critical ailments. In addition, the demand for biotech solutions is also high across other sectors such as food and agriculture. So, biotech stocks such as Leap Therapeutics (LPTX) and Corvus Pharmaceutical...

The following slide deck was published by Leap Therapeutics, Inc. in conjunction with this event. For further details see: Leap Therapeutics (LPTX) ESMO 2021Virtual Congress Presentation - Slideshow

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire CAMBRIDGE, Mass. , Sept. 24, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasd...

Leap Therapeutics Inc. (NASDAQ:LPTX) traded today at a new 52-week high of $3.75. Approximately 9.7 million shares have changed hands today, as compared to an average 30-day volume of 8.3 million shares. Potential upside of 79.7% exists for Leap Therapeutics Inc., based on a current leve...